IAN
MRNA icon

Integrated Advisors Network’s Moderna MRNA Stock Holding History

Integrated Advisors Network’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,948
Closed -$231K – 733
2024
Q2 		$231K Sell
1,948
-113
-5% -$14.3K 0.01% 629
2024
Q1 		$220K Buy
+2,061
New +$208K 0.01% 664
2023
Q3 		– Sell
-2,046
Closed -$249K – 686
2023
Q2 		$249K Buy
2,046
+46
+2% +$6.14K 0.01% 585
2023
Q1 		$307K Sell
2,000
-4,290
-68% -$708K 0.02% 540
2022
Q4 		$1.13M Buy
6,290
+4,564
+264% +$746K 0.07% 269
2022
Q3 		$204K Buy
1,726
+18
+1% +$2.73K 0.01% 595
2022
Q2 		$244K Buy
1,708
+172
+11% +$24.6K 0.02% 573
2022
Q1 		$265K Sell
1,536
-392
-20% -$66K 0.02% 569
2021
Q4 		$490K Sell
1,928
-369
-16% -$108K 0.03% 419
2021
Q3 		$884K Buy
2,297
+1,106
+93% +$408K 0.06% 288
2021
Q2 		$280K Buy
+1,191
New +$213K 0.02% 496

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Integrated Advisors Network's MRNA Position: Q3 2024 in Review

Integrated Advisors Network sold out of Moderna (MRNA) in Q3 2024, closing a stake of 1,948 shares — an estimated $231K sold.

Integrated Advisors Network first reported a position in MRNA in Q2 2021 and held it in 11 quarters. The position peaked at $1.13M in Q4 2022. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Integrated Advisors Network reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Integrated Advisors Network sold 1,948 Moderna shares in Q3 2024, an estimated $231K.
  • Integrated Advisors Network first reported a position in Moderna in Q2 2021 and held it in 11 quarters.
  • Integrated Advisors Network's Moderna position peaked at $1.13M in Q4 2022.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Integrated Advisors Network's 13F filing for Q3 2024, filed 25 Oct 2024.